Fresenius Kidney Care:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Fresenius Kidney Care - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3464
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Fresenius Kidney Care (FMCNA), formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical information system, bloodlines and concentrates, home therapy products and others; its home therapy products include peritoneal dialysis products and home hemodialysis products. FMCNA offers services such as patient care, laboratory services, customer and technical support, courier services, education and training, managed care, billing, physician services, inpatient services and research services. The company also offers recopies for breakfasts, lunches, dinners, snacks and beverages. It has operations in Utah and California. FMCNA is headquartered in Waltham, Massachusetts, the US.

Fresenius Kidney Care – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Partnerships 12
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
Asset Transactions 14
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care – Key Competitors 15
Fresenius Kidney Care – Key Employees 16
Fresenius Kidney Care – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Legal and Regulatory 18
Jan 07, 2017: Statement of Fresenius Medical Care Regarding Lawsuit Challenging Premium Assistance Regulation 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Key Facts 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Fresenius Medical Care Acquires Therapeutic Apheresis Assets from HemaCare 11
Apollo Medical Enters Into Agreement With Fresenius Medical Care For End Stage Renal Disease 12
Heritage California Enters Into Agreement With Fresenius Medical For End Stage Renal Disease 13
DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 14
Fresenius Kidney Care, Key Competitors 15
Fresenius Kidney Care, Key Employees 16

List of Figures
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Fresenius Kidney Care, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Fresenius Kidney Care, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Fresenius Kidney Care:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VSE Corporation (VSEC):企業の財務・戦略的SWOT分析
    VSE Corporation (VSEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Koninklijke Philips NV (PHIA):企業の財務・戦略的SWOT分析
    Koninklijke Philips NV (PHIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Renova Energia SA (RNEW11)-エネルギー分野:企業M&A・提携分析
    Summary Renova Energia S.A. (Renova Energia) is a renewable power generation company. It develops, implements and operates power generation projects based on renewable energy sources such as wind, small hydropower and solar; and sells electricity. It also undertakes activities related to manufacturi …
  • permanent tsb Group Holdings p.l.c.:企業の戦略・SWOT・財務情報
    permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report Summary permanent tsb Group Holdings p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析
    Summary Evogene Ltd (Evogene), a subsidiary of Compugen Ltd, is a biotechnology company that offers plant genomic services. The company offers solutions for crop production improvement through breeding. It develops biotechnology and advanced breeding improved traits for crops that feed the world, in …
  • Werner Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Werner Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ATCO Power Ltd:企業の戦略的SWOT分析
    ATCO Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Myriad RBM Inc-医療機器分野:企業M&A・提携分析
    Summary Myriad RBM Inc (Myriad RBM), formerly Rules Based Medicine Inc, a subsidiary of Myriad Genetics Inc, is an immunoassay testing laboratory that provides protein biomarker products and services. The company’s products and services include HumanMAP services that assist investigators in the disc …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Langley Holdings plc:企業の戦略・SWOT・財務分析
    Langley Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Langley Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ET Solar Group Corporation:電力:M&Aディール及び事業提携情報
    Summary ET Solar Group Corporation (ET Solar) is a provider of renewable energy equipment and services. The company produces a variety of photovoltaic (PV) modules based on global standards such as IEC, TUV, VDE, and UL. It also provides horizontally integrated project development; finance and inves …
  • Ornua Co-operative Limited:企業の戦略・SWOT・財務情報
    Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Jcb Co., Ltd.:企業の戦略・SWOT・財務分析
    Jcb Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Jcb Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Energy Resources of Australia Ltd (ERA):企業の財務・戦略的SWOT分析
    Energy Resources of Australia Ltd (ERA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Asos Plc:企業の戦略・SWOT・財務分析
    Asos Plc - Strategy, SWOT and Corporate Finance Report Summary Asos Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Campofrio Food Group, S.A.:企業の戦略・SWOT・財務情報
    Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report Summary Campofrio Food Group, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • CAP S.A.:企業の戦略・SWOT・財務情報
    CAP S.A. - Strategy, SWOT and Corporate Finance Report Summary CAP S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Roust Corporation:企業の戦略・SWOT・財務情報
    Roust Corporation - Strategy, SWOT and Corporate Finance Report Summary Roust Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Medizone International Inc (MZEI):企業の財務・戦略的SWOT分析
    Summary Medizone International Inc (Medizone) is a medical device company that develops aseptic treatment. The company provides disinfectant products used in surgical and other medical treatment facilities. Its product includes AsepticSure hospital sterilization system. Medizone’s AsepticSure is an …
  • Hudson’s Bay Company (HBC):企業の財務・戦略的SWOT分析
    Hudson's Bay Company (HBC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆